Company / Current Assets
LEXICON PHARMACEUTICALS, INC. Current Assets History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$101.9M
FY2025
5-year range
$101.9M / $246.2M
FY2021-FY2025
Trend
-58.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $102M in FY2025 to $532M in FY2015.
Based on SEC 10-K filings.
$102M in FY2025 with a 10-year CAGR of -15.2%.
Declined from $177M to $102M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -15.2%
Key checks
Key Insights
- In FY2025, current assets decreased 58.6% year-over-year.
- Peak current assets was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $101.9M | -58.6% |
| FY2024 | $246.2M | +39.4% |
| FY2023 | $176.5M | +25.3% |
| FY2019 | $140.9M | -18.7% |
| FY2018 | $173.3M | -46.2% |
| FY2017 | $322.0M | -10.0% |
| FY2016 | $357.9M | -32.8% |
| FY2015 | $532.4M | +44.3% |
| FY2014 | $369.0M | +174.2% |
| FY2013 | $134.6M | -41.7% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026